Title:
異常Bリンパ球増殖の治療におけるHLA-Gの可溶型の使用
Document Type and Number:
Japanese Patent JP5539982
Kind Code:
B2
Abstract:
The invention relates to a novel use of the soluble forms of HLA-G in the treatment or prophylaxis of abnormal B-cell proliferation, such as liquid cancers of the B type.
Inventors:
Ruas-Freys, Natalie
Carrosella, Edgard Delfino
Carrosella, Edgard Delfino
Application Number:
JP2011520555A
Publication Date:
July 02, 2014
Filing Date:
July 31, 2009
Export Citation:
Assignee:
F. HOFFMANN-LA ROCHE AKTIENGESELLSCHAFT
International Classes:
A61K39/00; A61K45/00; A61P35/00; A61P35/02
Domestic Patent References:
| JP2007520428A | ||||
| JP2000507214A |
Foreign References:
| FR2810047A1 |
Other References:
MENIER C,HLA-G5 TURNS OFF SIGNALLING BY ERYTHROPOIETIN RECEPTOR,TISSUE ANTIGENS,デンマーク,MUNKSGAARD,2006年10月 1日,V68 N4,P352
REBMANN,HLA-G IN B-CHRONIC LYMPHOCYTIC LEUKAEMIA: CLINICAL RELEVANCE AND FUNCTIONAL IMPLICATIONS,SEMINARS IN CANCER BIOLOGY,米国,SAUNDERS SCIENTIFIC PUBLICATIONS,2007年11月 9日,V17 N6,P430-435
GROS F,SOLUBLE HLA-G MOLECULES ARE INCREASED DURING ACUTE LEUKEMIA, 以下備考,NEOPLASIA,2006年 3月 1日,V8 N3,P223-230,ESPECIALLY IN SUBTYPES AFFECTING MONOCYTIC AND LYMPHOID LINEAGES
REBMANN,HLA-G IN B-CHRONIC LYMPHOCYTIC LEUKAEMIA: CLINICAL RELEVANCE AND FUNCTIONAL IMPLICATIONS,SEMINARS IN CANCER BIOLOGY,米国,SAUNDERS SCIENTIFIC PUBLICATIONS,2007年11月 9日,V17 N6,P430-435
GROS F,SOLUBLE HLA-G MOLECULES ARE INCREASED DURING ACUTE LEUKEMIA, 以下備考,NEOPLASIA,2006年 3月 1日,V8 N3,P223-230,ESPECIALLY IN SUBTYPES AFFECTING MONOCYTIC AND LYMPHOID LINEAGES
Attorney, Agent or Firm:
Shintaro Nogawa
Masanori Akiyama
Shinji Kai
Yusuke Kaneko
Kiyoshi Inamoto
Masanori Akiyama
Shinji Kai
Yusuke Kaneko
Kiyoshi Inamoto